The mutational profile of MM is characterized by both different mutations within the subclones (e.g., BRAF mutation in 50%) and multiple mutations within the same signaling pathway (e.g., KRAS, NRAS and BRAF mutations within the MAPK pathway) [14,16,28]. This evidence concerns the gene NRAS and Miyoshi myopathy.